T1	Gene_or_gene_product 26 39	interleukin-6
T2	Gene_or_gene_product 41 45	IL-6
T3	Gene_or_gene_product 90 103	Interleukin-6
T4	Gene_or_gene_product 105 109	IL-6
T5	Gene_or_gene_product 275 288	Interleukin-6
T7	Pathological_formation 326 331	tumor
T10	Cell 368 380	cancer cells
T13	Gene_or_gene_product 429 433	IL-6
T14	Gene_or_gene_product 555 559	IL-6
T15	Pathological_formation 612 641	non-small cell lung carcinoma
T16	Pathological_formation 662 682	renal cell carcinoma
T17	Pathological_formation 684 690	breast
T18	Gene_or_gene_product 717 721	IL-6
T19	Pathological_formation 744 749	tumor
T20	Gene_or_gene_product 828 832	IL-6
T21	Pathological_formation 907 920	breast cancer
T11	Pathological_formation 592 610	endometrial cancer
T22	Pathological_formation 643 660	colorectal cancer
T23	Pathological_formation 695 709	ovarian cancer
T24	Pathological_formation 888 905	colorectal cancer
T25	Pathological_formation 922 936	gastric cancer
T26	Pathological_formation 941 958	pancreatic cancer
T27	Organism_substance 549 554	serum
T1000	Organism 578 586	patients
T1001	Organism 773 781	patients
T28	Pathological_formation 73 79	cancer
T32	Pathological_formation 504 510	cancer
T34	Organism_substance 711 716	Serum
T36	Gene_or_gene_product 424 433	Anti-IL-6
T12	Blood_vessel_development 410 422	angiogenesis
T6	Development 332 343	progression
E6	Development:T6 Theme:T7
T8	Negative_regulation 354 364	inhibition
E8	Negative_regulation:T8 Theme:E9 Cause:T5
T9	Death 381 390	apoptosis
E9	Death:T9 Theme:T10
R1	frag Arg1:T17 Arg2:T23	
*	Equiv T1 T2
*	Equiv T3 T4
T29	Regulation 310 320	associated
E1	Regulation:T29 Theme:E6 Cause:T5
T30	Positive_regulation 395 406	stimulation
E2	Positive_regulation:T30 Cause:T5 Theme:E7
T31	Planned_process 434 441	therapy
E3	Planned_process:T31 Theme:T32 Instrument:T36
T33	Positive_regulation 540 548	elevated
E4	Positive_regulation:T33 Theme:T14
T35	Death 761 769	survival
E5	Death:T35 Theme:T1001
A1	Negation E5
E7	Blood_vessel_development:T12 
